tiprankstipranks
Trending News
More News >
Sagimet Biosciences, Inc. Class A (SGMT)
:SGMT
US Market

Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

Compare
1,215 Followers

Total Valuation

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $170.55M. The enterprise value is $24.24M.
Market Cap$170.55M
Enterprise Value$24.24M

Share Statistics

Sagimet Biosciences, Inc. Class A has 30,674,854 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,674,854
Owned by Insiders10.58%
Owned by Institutions23.57%

Financial Efficiency

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.93%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-34.93%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee0.00
Profits Per Employee-3.25M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Sagimet Biosciences, Inc. Class A is -3.10. Sagimet Biosciences, Inc. Class A’s PEG ratio is 0.64.
PE Ratio-3.10
PS Ratio0.00
PB Ratio0.67
Price to Fair Value0.91
Price to FCF-2.36
Price to Operating Cash Flow-2.47
PEG Ratio0.64

Income Statement

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -45.57M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit0.00
Operating Income-54.45M
Pretax Income-45.57M
Net Income-45.57M
EBITDA-45.57M
Earnings Per Share (EPS)-1.45

Cash Flow

In the last 12 months, operating cash flow was -42.44M and capital expenditures 0.00, giving a free cash flow of -42.44M billion.
Operating Cash Flow-42.44M
Free Cash Flow-42.44M
Free Cash Flow per Share-1.38

Dividends & Yields

Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta3.64
52-Week Price Change13.93%
50-Day Moving Average3.13
200-Day Moving Average4.06
Relative Strength Index (RSI)82.58
Average Volume (3m)1.39M

Important Dates

Sagimet Biosciences, Inc. Class A upcoming earnings date is Aug 25, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 25, 2025
Ex-Dividend Date

Financial Position

Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of 0.05%
Current Ratio34.30
Quick Ratio34.30
Debt to Market Cap<0.01
Net Debt to EBITDA1.66
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.43, with an EV/FCF ratio of -1.54.
EV to Sales0.00
EV to EBITDA-1.43
EV to Free Cash Flow-1.54
EV to Operating Cash Flow-1.54

Balance Sheet

Sagimet Biosciences, Inc. Class A has $151.25M in cash and marketable securities with $78.00K in debt, giving a net cash position of -$151.17M billion.
Cash & Marketable Securities$151.25M
Total Debt$78.00K
Net Cash-$151.17M
Net Cash Per Share-$4.93
Tangible Book Value Per Share$4.97

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Sagimet Biosciences, Inc. Class A is $28.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$28.75
Price Target Upside604.66% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-100.00%
EPS Growth Forecast-12.66%

Scores

Smart Score10
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis